<code id='847669DB80'></code><style id='847669DB80'></style>
    • <acronym id='847669DB80'></acronym>
      <center id='847669DB80'><center id='847669DB80'><tfoot id='847669DB80'></tfoot></center><abbr id='847669DB80'><dir id='847669DB80'><tfoot id='847669DB80'></tfoot><noframes id='847669DB80'>

    • <optgroup id='847669DB80'><strike id='847669DB80'><sup id='847669DB80'></sup></strike><code id='847669DB80'></code></optgroup>
        1. <b id='847669DB80'><label id='847669DB80'><select id='847669DB80'><dt id='847669DB80'><span id='847669DB80'></span></dt></select></label></b><u id='847669DB80'></u>
          <i id='847669DB80'><strike id='847669DB80'><tt id='847669DB80'><pre id='847669DB80'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:173
          Jeremey Wyatt ActiGraph

          As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

          The Pensacola, Fla.-based company creates  devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

          advertisement

          There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          South Korea throws huge K

          1:30AttendeesoftheWorldScoutJamboreewatchaK-PopconcertaftertheclosingceremonyoftheWorldScoutJamboree